Roundhill GLP-1 & Weight Loss ETF
OZEM
#2852
ETF rank
C$73.47 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$44.26
Share price
1.12%
Change (1 day)
40.02%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of April 16, 2026Number of holdings: 28

Full holdings list

Weight %NameTickerShares Held
15.29%
Eli Lilly & CoLLY9003
14.08%
Novo Nordisk A/SNVO183834
7.06%
Pfizer IncPFE138419
5.56%
Viking Therapeutics IncVKTX83569
5.31%
Innovent Biologics Inc1801 HK242500
4.84%
Ascletis Pharma Inc1672 HK1133000
3.92%
Roche Holding AGROP SW5146
3.76%
Amgen IncAMGN5762
3.71%
AstraZeneca PLCAZN9819
3.64%
Hanmi Pharm Co Ltd128940 KS5593
3.61%
Zealand Pharma A/SZEAL DC40685
3.35%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.28%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
3.14%
Regeneron Pharmaceuticals IncREGN2218
2.93%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.58%
Structure Therapeutics IncGPCR25378
2.36%
United Laboratories International Holdings Ltd/The3933 HK954000
2.32%
Gubra A/SGUBRA DC22723
2.12%
MBX Biosciences IncMBX34264
1.85%
Gilead Sciences IncGILD7043
1.39%
Rhythm Pharmaceuticals IncRYTM8463
1.27%
Shionogi & Co Ltd4507 JP32700
1.04%
First American Government Obligations Fund 12/01/2031FGXXX553171.68
1.03%
Biohaven LtdBHVN53094
0.47%
WaVe Life Sciences LtdWVE32778
0.42%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.18%
Cash & OtherCash&Other98240.04
-0.52%
SWISS FRANCCHF-215321.29